The field of short-sellers has shrunk dramatically since the Department of Justice's probe was revealed earlier this year. However, some stalwart investors remain committed to the cause of unveiling potentially fraudulent companies.
Background On Cassava Sciences, Formerly Known As Pain Therapeutics
At the SohnX Hong Kong Conference, reputable short-seller Gabriel Grego of Quintessential Capital Management unmasked the individuals behind Cassava Sciences, previously known as Pain Therapeutics. He also explained why he sees problems at the company that has caused him to flag it as potentially fraudulent.
Q2 2022 hedge fund letters, conferences and more
Grego began his campaign against Cassava Sciences in November 2021, although he suggested that some investors might...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
